glyburide and pioglitazone

glyburide has been researched along with pioglitazone in 65 studies

Research

Studies (65)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (6.15)18.2507
2000's29 (44.62)29.6817
2010's24 (36.92)24.3611
2020's8 (12.31)2.80

Authors

AuthorsStudies
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Darvesh, AS; Geldenhuys, WJ; Leeper, TC; Morris, DL; Sullivan, PG; Yonutas, HM1
Ahn, S; An, S; Choi, JM; Choi, MS; Kwon, SW; Le, THV; Lee, J; Lee, M; Ma, CT; Noh, M; Park, JH; Pyo, JJ1
Norman, BH1
An, S; Choi, H; Hyun, YE; Jeong, LS; Kim, G; Kim, JA; Nguyen, M; Nguyen, Y; Noh, M; Pham, L1
An, S; Deyrup, ST; Hur, JS; Kim, J; Ko, H; Lee, JW; Noh, M; Shim, SH1
Hodorek, MJ; Iannucci, AR; Peuler, JD; Phare, SM1
Diani, A; Messina, JL; Murray, FT; Sangani, GA; Wachowski, MB; Weinstock, RS1
Bourghli, M; Miller, JA; Peuler, JD; Soltis, EE; Sowers, JR; Zammam, HY1
Gonoi, T; Inagaki, N; Ishida, H; Seino, S; Seino, Y; Sunaga, Y; Yamada, Y1
Ebeling, P; Koistinen, HA; Koivisto, VA; Teppo, AM1
Ebihara, I; Koide, H; Nakamura, T; Osada, S; Shimada, N; Ushiyama, C1
Abe, T; Ishibashi, S; Ishikawa, S; Kawakami, A; Kusaka, I; Nagasaka, S; Nakamura, T; Saito, T1
Braddon, J; Phillips, P1
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T1
Chandalia, HB; Fafadia, A; Joshi, SR; Panikar, V; Santvana, C1
Clausen, J; Eriksson, JW; Halse, J; Herz, M; Johns, D; Konkoy, CS; Madsbad, S; Strand, J; Tan, MH1
Croom, DK; Lenhard, JM; Minnick, DT1
Anazawa, T; Kanmatsuse, K; Kushiro, T; Tani, S; Watanabe, I1
Chow, CC; Filipczak, R; Joshi, P; Lertoft, B; Rastam, J; Raz, I; Shaban, J; Stranks, S1
Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P1
Itoh, Y; Mori, Y; Obata, T; Tajima, N1
Costa, DB; Huberman, MS1
Forst, T; Hanefeld, M; Lübben, G; Pfützner, A1
Hara, M; Nakagawa, M; Ooie, T; Saikawa, T; Shinohara, T; Takahashi, N; Taniguchi, Y; Yonemochi, H; Yoshimatsu, H1
Dorkhan, M; Frid, A; Groop, L; Grubb, A; Jovinge, S; Magnusson, M1
Jain, R; Kupfer, S; Osei, K; Perez, AT; Zhang, J1
Ari, N; Aslamaci, S; Irat, AM; Karasu, C1
Ebeling, P; Heliövaara, MK; Herz, M; Leinonen, E; Teppo, AM1
Willeke, A1
Bellatreccia, A; Comaschi, M; Demicheli, A; Di Pietro, C; Mariz, S1
Bellatreccia, A; Comaschi, M; Corsi, A; Di Pietro, C; Mariz, S1
Al Majali, K; Bailey, CJ; Betteridge, DJ; Cooper, MB1
Balez, S; Bullock, J; Dole, WP; He, YL; Jarugula, V; Ligueros-Saylan, M; Riviere, GJ; Schwartz, S; Serra, D; Wang, Y1
Birnbaum, Y; Lin, Y; Perez-Polo, JR; Ye, Y1
Aso, Y; Hara, K; Haruki, K; Inukai, T; Matsumoto, S; Nakamachi, T; Nakano, T; Ozeki, N; Suetsugu, M; Takebayashi, K; Yatsuka, C1
Adams-Huet, B; Kaloyanova, PF; Legendre, JL; Lingvay, I; Raskin, P; Zhang, S1
Fleck, P; Karim, A; Laurent, A; Mekki, Q; Munsaka, M; Wann, E1
Freston, JW; Kupfer, S; Perez, A; Tolman, KG1
Abdul-Razzak, KK; Al-Azzam, SI; Jaradat, MW1
Baraka, A; ElGhotny, S1
Arayne, MS; Mirza, AZ; Sultana, N1
Boulton, DW; Brenner, E; Handschuh del Corral, M; Komoroski, B; Kornhauser, D; Li, L; Patel, CG; Vachharajani, N1
Bianchi, L; Cicero, AF; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P1
Scheen, AJ1
Greyson, CR; Lu, L; Reiter, MJ; Sarraf, M; Schwartz, GG; Ye, S1
Alonso, E; Aparicio, I; Buchberger, W; Martín, J; Santos, JL1
Adams-Huet, B; Harrison, LB; Lingvay, I; Raskin, P1
Duong, J; Leonard, D; Lingvay, I; Roe, ED; Szczepaniak, LS1
Carbone, A; Cicero, AF; D'Angelo, A; Derosa, G; Fogari, E; Franzetti, IG; Maffioli, P; Piccinni, MN; Querci, F2
D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Perrone, T1
AbuKhader, MM; Alqtaishat, S; Khanfar, MA; Taha, MO1
Chen, SH; Liu, XN; Peng, Y; Sun, QY1
Bombicz, M; Hegedűs, C; Juhász, B; Kiss, R; Kovács, D; Németh, J; Priksz, D; Szabó, AM; Szilvássy, Z; Varga, B; Wachal, Z1
Cheng, PW; Lin, HL; Shen, KP; Tu, YC; Wu, BN; Yeh, BC1
Aiceles de Medeiros Pinto, V; da Fonte Ramos, C; Devantier Neuenfeldt, P; Gonçalves Marques Elias, R; Mena Barreto Silva, FR; Nunes, RJ; Pires Mendes, C; Postal, BG; Silva Frederico, MJ1
Cheng, PW; Hao, CL; Lin, HL; Shen, KP; Tu, YC; Wu, BN; Yeh, BC1
Jannetto, PJ; Langman, LJ1

Reviews

6 review(s) available for glyburide and pioglitazone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
    Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20

    Topics: Animals; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Drug Discovery; Drug Evaluation, Preclinical; Hepatocytes; Humans; Liver; Mitochondria, Liver; Pharmaceutical Preparations; Risk Assessment; Tissue Distribution

2020
Oral hypoglycaemics. When not to use what.
    Australian family physician, 2002, Volume: 31, Issue:7

    Topics: Acarbose; Acidosis, Lactic; Aged; Contraindications; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Pioglitazone; Renal Insufficiency; Rosiglitazone; Thiazoles; Thiazolidinediones

2002
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52

    Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors

2003
Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation).
    Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:12

    Topics: Area Under Curve; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Linagliptin; Metformin; Pioglitazone; Purines; Quinazolines; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones

2011
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
    Journal of cellular physiology, 2019, Volume: 234, Issue:3

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin

2019

Trials

24 trial(s) available for glyburide and pioglitazone

ArticleYear
Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:3

    Topics: Acute-Phase Proteins; Blood Glucose; Blood Proteins; C-Reactive Protein; Complement Activation; Complement C3; Complement C3a; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Osmolar Concentration; Pioglitazone; Thiazoles; Thiazolidinediones

2001
Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes.
    Renal failure, 2001, Volume: 23, Issue:6

    Topics: Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Pioglitazone; Renal Dialysis; Thiazoles; Thiazolidinediones; Triglycerides

2001
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:8

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Pioglitazone; Thiazolidinediones

2004
Effect of pioglitazone on arteriosclerosis in comparison with that of glibenclamide.
    Diabetes research and clinical practice, 2005, Volume: 68, Issue:2

    Topics: Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Glyburide; Humans; Insulin Resistance; Male; Middle Aged; Pioglitazone; Pulse; Risk Factors; Thiazolidinediones; Time Factors; Triglycerides

2005
Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.
    Clinical therapeutics, 2005, Volume: 27, Issue:9

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Pioglitazone; Thiazolidinediones; Time Factors; Triglycerides; Weight Gain

2005
Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.
    Endocrine, 2006, Volume: 29, Issue:1

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoprotein Lipase; Male; Middle Aged; Oxidative Stress; Pioglitazone; Postprandial Period; Thiazolidinediones; Time Factors; Triglycerides; Tyrosine

2006
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study.
    Current medical research and opinion, 2006, Volume: 22, Issue:6

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Pioglitazone; Primary Health Care; Prospective Studies; Thiazolidinediones; Treatment Outcome

2006
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
    Journal of internal medicine, 2006, Volume: 260, Issue:2

    Topics: Adiponectin; Administration, Oral; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pioglitazone; Proinsulin; Prospective Studies; Statistics, Nonparametric; Thiazolidinediones

2006
Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
    Pharmacotherapy, 2006, Volume: 26, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Risk Assessment; Thiazolidinediones; Time Factors

2006
Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes.
    Journal of endocrinological investigation, 2007, Volume: 30, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Hemoglobins; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Orosomucoid; Pioglitazone; Serum Amyloid A Protein; Thiazolidinediones

2007
Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes.
    Diabetes technology & therapeutics, 2007, Volume: 9, Issue:4

    Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Metformin; Pioglitazone; Safety; Thiazolidinediones

2007
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2008, Volume: 18, Issue:5

    Topics: Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Dyslipidemias; Female; Glyburide; Humans; Hypoglycemic Agents; Italy; Male; Metformin; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triglycerides

2008
Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
    Clinical endocrinology, 2008, Volume: 68, Issue:5

    Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Pioglitazone; Postprandial Period; Proinsulin; Thiazolidinediones

2008
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.
    International journal of clinical pharmacology and therapeutics, 2008, Volume: 46, Issue:7

    Topics: Adamantane; Adult; Aged; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nitriles; Pioglitazone; Pyrrolidines; Thiazolidinediones; Vildagliptin

2008
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?
    Diabetes care, 2009, Volume: 32, Issue:10

    Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones; Treatment Outcome; Young Adult

2009
Coadministration of pioglitazone or glyburide and alogliptin: pharmacokinetic drug interaction assessment in healthy participants.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Piperidines; Thiazolidinediones; Uracil

2009
Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.
    Drug safety, 2009, Volume: 32, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Approval; Endpoint Determination; Female; Glyburide; Humans; Hypoglycemic Agents; Liver Function Tests; Male; Middle Aged; Pioglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Young Adult

2009
Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects.
    Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:7

    Topics: Adamantane; Adolescent; Adult; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones; Young Adult

2011
Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011, Volume: 43, Issue:7

    Topics: Administration, Oral; Biomarkers; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Lipids; Male; Pioglitazone; Thiazolidinediones

2011
β-cell function preservation after 3.5 years of intensive diabetes therapy.
    Diabetes care, 2012, Volume: 35, Issue:7

    Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Patient Compliance; Pioglitazone; Thiazolidinediones

2012
Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2012, Volume: 60, Issue:7

    Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Disease Progression; Fatty Liver; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones; Triglycerides; Young Adult

2012
A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy.
    Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:7

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles

2013
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.
    Diabetes technology & therapeutics, 2013, Volume: 15, Issue:3

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Obesity; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles

2013
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:9

    Topics: Adipokines; Aged; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fatty Liver; Female; Fluorobenzenes; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Intra-Abdominal Fat; Italy; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrimidines; Rosuvastatin Calcium; Subcutaneous Fat; Sulfonamides; Thiazolidinediones; Time Factors; Treatment Outcome; Ultrasonography

2013

Other Studies

35 other study(ies) available for glyburide and pioglitazone

ArticleYear
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index

2014
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
    Bioorganic & medicinal chemistry letters, 2016, 11-01, Volume: 26, Issue:21

    Topics: Hypoglycemic Agents; Ligands; Mitochondrial Proteins; Protein Binding; Small Molecule Libraries; Thiazolidinediones

2016
Adiponectin-Secretion-Promoting Phenylethylchromones from the Agarwood of Aquilaria malaccensis.
    Journal of natural products, 2019, 02-22, Volume: 82, Issue:2

    Topics: Adiponectin; Cells, Cultured; Chromones; Humans; PPAR gamma; Thymelaeaceae; Wood

2019
Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.
    ACS medicinal chemistry letters, 2022, Jul-14, Volume: 13, Issue:7

    Topics:

2022
Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus,
    Journal of natural products, 2022, 12-23, Volume: 85, Issue:12

    Topics: Adiponectin; Ascomycota; Humans; Naphthols; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR gamma

2022
Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation.
    American journal of hypertension, 1996, Volume: 9, Issue:2

    Topics: Animals; Aorta, Thoracic; Cattle; Cell Division; Cells, Cultured; Fetal Blood; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Metformin; Muscle, Smooth, Vascular; Pioglitazone; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidinediones

1996
Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.
    Pharmacology, 1997, Volume: 54, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Hepatocellular; Cell Division; Diabetes Mellitus, Type 2; DNA; Dose-Response Relationship, Drug; Drug Synergism; Glyburide; Hypertrophy; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Pioglitazone; Rats; Thiazoles; Thiazolidinediones; Tumor Cells, Cultured

1997
Disparate effects of antidiabetic drugs on arterial contraction.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:10

    Topics: Animals; Arteries; Blood Pressure; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Metformin; Muscle Contraction; Muscle, Smooth, Vascular; Pioglitazone; Potassium Chloride; Rats; Rats, Wistar; Tail; Thiazoles; Thiazolidinediones

1997
Troglitazone but not pioglitazone affects ATP-sensitive K(+) channel activity.
    European journal of pharmacology, 1999, Sep-17, Volume: 381, Issue:1

    Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Chromans; COS Cells; Diazoxide; Electrophysiology; Glyburide; Membrane Potentials; Pinacidil; Pioglitazone; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Recombinant Fusion Proteins; Rubidium Radioisotopes; Sulfonylurea Receptors; Thiazoles; Thiazolidinediones; Transfection; Troglitazone

1999
Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success.
    Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:4

    Topics: Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liver; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones; Troglitazone

2002
Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy.
    The Journal of the Association of Physicians of India, 2003, Volume: 51

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones

2003
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments.
    Biochemical and biophysical research communications, 2004, Nov-05, Volume: 324, Issue:1

    Topics: Aging; Animals; Blood Glucose; Cell Membrane; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Hemoglobins; Hypoglycemic Agents; Insulin; Kidney; Liver; Male; Metformin; Peptide Fragments; Pioglitazone; PPAR gamma; Protein Precursors; Rats; Rats, Zucker; Thiazolidinediones

2004
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p
    Biomedical chromatography : BMC, 2006, Volume: 20, Issue:10

    Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones

2006
Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib.
    Diabetes care, 2006, Volume: 29, Issue:7

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diabetes Mellitus, Type 2; Erlotinib Hydrochloride; Female; Glyburide; Humans; Lung Neoplasms; Pioglitazone; Quinazolines; Thiazolidinediones

2006
Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat.
    Diabetes, 2006, Volume: 55, Issue:8

    Topics: Animals; Blotting, Western; Diabetes Mellitus, Type 2; Fever; Glucose Tolerance Test; Glyburide; HSP72 Heat-Shock Proteins; Hypoglycemic Agents; Insulin; Insulin Resistance; Kinetics; Male; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinases; Phosphorylation; Pioglitazone; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF; Thiazolidinediones; Ventricular Function, Left

2006
Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones.
    The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:12

    Topics: Aged; Cromakalim; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Mammary Arteries; Middle Aged; Nitroprusside; Phenylephrine; Pioglitazone; Potassium Channel Blockers; Potassium Chloride; Rosiglitazone; Thiazolidinediones; Vasoconstriction

2006
[Status of glitazones in treatment of type 2 diabetes mellitus].
    Der Internist, 2007, Volume: 48, Issue:7

    Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Disease Management; Drug Costs; Drug Therapy, Combination; Germany; Glyburide; Humans; Hypoglycemic Agents; Long-Term Care; Metformin; Pioglitazone; Practice Guidelines as Topic; Survival Analysis; Thiazolidinediones

2007
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
    Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Decanoic Acids; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glyburide; Hydroxy Acids; Injections, Intravenous; Intubation, Gastrointestinal; KATP Channels; Ligation; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Pioglitazone; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Thiazolidinediones; Ventricular Remodeling

2008
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes.
    Diabetes research and clinical practice, 2009, Volume: 85, Issue:2

    Topics: Adiponectin; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Patient Selection; Pioglitazone; Sex Characteristics; Thiazolidinediones

2009
The nephroprotective effects of pioglitazone and glibenclamide against gentamicin-induced nephrotoxicity in rats: a comparative study.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:2

    Topics: Animals; Antioxidants; Creatinine; Disease Models, Animal; Gentamicins; Glyburide; Kidney Diseases; Lipid Peroxidation; Male; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones

2010
Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
    European journal of pharmacology, 2010, Sep-01, Volume: 641, Issue:2-3

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Galanin; Glyburide; Hippocampus; Hypoglycemic Agents; Learning; Male; Memory; Pioglitazone; Rats; Rats, Wistar; tau Proteins; Thiazolidinediones

2010
Simultaneous determination of gliquidone, pioglitazone hydrochloride, and verapamil in formulation and human serum by RP-HPLC.
    Journal of chromatographic science, 2011, Volume: 49, Issue:2

    Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Glyburide; Humans; Linear Models; Pioglitazone; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds; Tablets; Thiazolidinediones; Verapamil

2011
Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.
    Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Death, Sudden, Cardiac; Decanoic Acids; Female; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Ischemia; Ischemic Preconditioning, Myocardial; Male; Pioglitazone; Potassium Channel Blockers; Rosiglitazone; Swine; Thiazolidinediones; Ventricular Fibrillation

2012
High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012, May-01, Volume: 895-896

    Topics: Chromatography, High Pressure Liquid; Drinking Water; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Mass Spectrometry; Metformin; Pioglitazone; Reproducibility of Results; Rivers; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Solid Phase Extraction; Thiazolidinediones; Water Pollutants, Chemical

2012
Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.
    Journal of molecular graphics & modelling, 2013, Volume: 42

    Topics: Adrenergic beta-Antagonists; Amino Acid Sequence; Anti-Infective Agents; Catalytic Domain; Crystallography, X-Ray; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metipranolol; Models, Molecular; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Pioglitazone; Quantitative Structure-Activity Relationship; ROC Curve; Sequence Alignment; Sotalol; Sulfamethizole; Thiazolidinediones; TOR Serine-Threonine Kinases

2013
Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone.
    International journal of molecular sciences, 2020, Mar-19, Volume: 21, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Glyburide; Humans; Hydroxamic Acids; Hypoglycemic Agents; Insulin; Male; Metformin; Molecular Structure; Oximes; Pioglitazone; Piperidines; Protective Agents; Rats; Rats, Wistar; Retina

2020
The effectiveness comparisons of eugenosedin-A, glibenclamide and pioglitazone on diabetes mellitus induced by STZ/NA and high-fat diet in SHR.
    The Journal of pharmacy and pharmacology, 2021, Apr-27, Volume: 73, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Glyburide; Hypertension; Hypoglycemic Agents; Insulin; Male; Pioglitazone; Piperazines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Streptozocin

2021
Synthesis of a novel glibenclamide-pioglitazone hybrid compound and its effects on glucose homeostasis in normal and insulin-resistant rats.
    Bioorganic chemistry, 2021, Volume: 114

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glyburide; Homeostasis; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Molecular Structure; Pioglitazone; Rats; Structure-Activity Relationship

2021
Efficiency comparison of an isoeugenol-derivated compound, eugenosedin-A, with glibenclamide and pioglitazone in protecting cardiovascular dysfunction of diabetic SHR.
    Journal of Asian natural products research, 2023, Volume: 25, Issue:5

    Topics: Animals; Diabetes Mellitus, Experimental; Glyburide; Hypoglycemic Agents; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley

2023
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide

2024